Moreover, our laboratory and others previously found that CBD alleviated liver injury of NAFLD by suppressing NF-κB and the NLRP3 inflammasome (Mridha et al., 2017; Huang et al., 2019). Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.